Vitamin D During In Vitro Fertilisation (IVF) - A Prospective Randomized Trial

Status

UNKNOWN

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01019785

Acronym

Delivery

Enrollment

1000

Registered

2009-11-25

Start date

2009-11-30

Completion date

Unknown

Last updated

2009-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Complication

Keywords

Pregnancy rate (pos test, live fetus at 12 weeks, baby home), Pregnancy complication (Pregnancy hypertension, SGA, diab), Thrombin generation

Brief summary

During IVF treatment women will be randomized into supplementation with a high or a low dose of Vitamin D Main outcome Laboratory pregnancy, live pregnancy at 12 weeks, Baby take home rate, OHSS Secondary outcome: 1. Pregnancy complications (pregnancy hypertension, SGA, Diabetes) 2.Thrombin generation

Interventions

DIETARY_SUPPLEMENTErgocalciferol

100 000 U drops is given once

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* All women initiating IVF treatment

Exclusion criteria

* Women that have entered the study before

Design outcomes

Primary

Measure	Time frame
Laboratory pregnancy, live pregnancy at 12 weeks, take home baby rate	4 weeks to 9 month

Secondary

Measure	Time frame
Pregnancy complications (pregnancy hypertension, SGA, diabetes)	9 months

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026